ADVFN Logo ADVFN

No pudimos encontrar ningún resultado para:
Asegúrate de que la ortografía sea correcta o intenta ampliar tu búsqueda.

Tendencias Ahora

Listas Principales

Parece que no has iniciado sesión.
Haz clic en el botón de abajo para iniciar sesión y ver tu historial reciente.

Regístrate

¿Ya eres miembro? Iniciar sesión

Los Principales Corredores en Línea

Más Corredores en Línea

Datos
Noticias
Herramientas
Mercados
Descubrir

Hot Features

Follow Feed

Conéctese con traders e inversores en nuestra comunidad Follow Feed.

Flujo de Opciones

Explora datos de opciones completos y utiliza filtros avanzados con Options Flow.

Monitor

Organiza y monitorea tu lista de seguimiento de acciones y activos con Monitor.
Iniciar Sesión Premium IconPremium Help Menu
S&P 500
5,473.23
0.00%
Dow Jones
38,778.10
0.00%
US Dollar vs MXN
18.35716
-0.96%
Brent Oil
83.835
-0.08%
Bitcoin
64,885.39
-2.41%
Registration Strip Icon for monitor Monitoree múltiples cotizaciones en tiempo real de los principales intercambios, como la Bolsa de Valores de Londres, NASDAQ, NYSE, AMEX, Bovespa y más.
Regístrate
  1. Inicio
  2. Invertir
  3. Acciones
  4. Estados Unidos
  5. NASDAQ
  6. Xencor Inc (XNCR)

  7. Xencor Inc (XNCR) Noticias

XNCR

Xencor (XNCR)

Xencor Inc
Fecha:
Ordernar por:
 Showing the most relevant articles for your search:NASDAQ:XNCR
FechaHoraFuenteTítuloSímboloCompañía
17/06/202415:25Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:XNCRXencor Inc
14/06/202415:03Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:XNCRXencor Inc
13/06/202407:01Business WireXencor Regains CD20 x CD3 Bispecific T-Cell EngagerNASDAQ:XNCRXencor Inc
09/05/202415:09Business WireXencor Reports First Quarter 2024 Financial ResultsNASDAQ:XNCRXencor Inc
09/05/202415:02Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:XNCRXencor Inc
09/04/202407:01Business WireXencor Appoints Bart Cornelissen as Chief Financial OfficerNASDAQ:XNCRXencor Inc
11/03/202414:47Edgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNASDAQ:XNCRXencor Inc
28/02/202415:01Business WireXencor to Present at Upcoming Investor ConferencesNASDAQ:XNCRXencor Inc
27/02/202415:01Business WireXencor Reports Fourth Quarter and Full Year 2023 Financial ResultsNASDAQ:XNCRXencor Inc
20/02/202415:31Business WireXencor to Host Webcast to Review Fourth Quarter and Full Year 2023 Financial Results and Provide Vudalimab Clinical UpdateNASDAQ:XNCRXencor Inc
16/02/202416:43Edgar (US Regulatory)Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]NASDAQ:XNCRXencor Inc
03/01/202415:01Business WireXencor to Present at the 42nd Annual J.P. Morgan Healthcare ConferenceNASDAQ:XNCRXencor Inc
02/01/202407:01Business WireDane Leone Joins Xencor as Senior Vice President, Corporate StrategyNASDAQ:XNCRXencor Inc
21/11/202315:01Business WireXencor to Present at the Piper Sandler 35th Annual Healthcare ConferenceNASDAQ:XNCRXencor Inc
07/11/202315:01Business WireXencor Reports Third Quarter 2023 Financial ResultsNASDAQ:XNCRXencor Inc
07/11/202315:01Business WireXencor Sells Portion of Royalties and Milestones from Ultomiris® and Monjuvi® to OMERS Life Sciences for $215 MillionNASDAQ:XNCRXencor Inc
03/11/202311:01Business WireXencor Presents Preclinical Data from Multiple XmAb® Research Programs at the SITC Annual MeetingNASDAQ:XNCRXencor Inc
31/10/202315:01Business WireXencor to Host Third Quarter 2023 Financial Results Webcast and Conference Call on November 7, 2023NASDAQ:XNCRXencor Inc
26/10/202307:01Business WireXencor Announces Planned Retirement of Chief Financial Officer John KuchNASDAQ:XNCRXencor Inc
27/09/202308:01Business WireXencor to Present Multiple Posters at the SITC Annual MeetingNASDAQ:XNCRXencor Inc
19/09/202315:30Edgar (US Regulatory)Form 3 - Initial statement of beneficial ownership of securitiesNASDAQ:XNCRXencor Inc
19/09/202315:01Business WireXencor Appoints Barbara J. Klencke, M.D., to Board of DirectorsNASDAQ:XNCRXencor Inc
03/08/202315:01Business WireXencor Reports Second Quarter 2023 Financial ResultsNASDAQ:XNCRXencor Inc
27/07/202307:01Business WireXencor to Host Second Quarter 2023 Financial Results Webcast and Conference Call on August 3, 2023NASDAQ:XNCRXencor Inc
22/06/202316:56Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:XNCRXencor Inc
16/06/202309:55Edgar (US Regulatory)Securities Registration: Employee Benefit Plan (s-8)NASDAQ:XNCRXencor Inc
16/06/202309:42Edgar (US Regulatory)Post-effective Amendment to an S-8 Filing (s-8 Pos)NASDAQ:XNCRXencor Inc
15/06/202305:05Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:XNCRXencor Inc
30/05/202317:01Business WireXencor Presents Clinical Results from Phase 1a Study of XmAb®564 at the EULAR 2023 CongressNASDAQ:XNCRXencor Inc
08/05/202316:16Edgar (US Regulatory)Quarterly Report (10-q)NASDAQ:XNCRXencor Inc
 Showing the most relevant articles for your search:NASDAQ:XNCR

Su Consulta Reciente

NYSE
OSG
Overseas Shipholding
USOTC
IFCZF
Intact Financial (PK)
ASX
PVM
LVCN
OCNETH
Odyssey OCoin
BIT
F36005
Vontobel Financial Produ...
LSE
GI38
Citi Fun 25
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

México
Empresa
Negocios
Popular
Obtener la aplicación
App Store
Google Play

Soporte: (55) 4170 8128 | soporte@advfn.mx

Al acceder a los servicios disponibles de ADVFN usted acepta quedar sujerto a los Términos y Condiciones

© 2024 ADVFN PLC - Todos los derechos reservados